Lack of association of apolipoprotein E allele ε4 with late-onset alzheimer’s disease among finnish centenarians

Neurology

Volumn 45, Issue 5, 1995, Pages 903-907

  Sobel, E ^a   Louhija, J ^c   Sulkava, R ^b   Davanipour, Z ^a   Kontula, K ^c   Miettinen, M ^c   Tikkanen, M ^c   Kainulainen, K ^c   Tilvis, R ^c  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; COGNITION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FINLAND; GENETIC PREDISPOSITION; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL;

AGE OF ONSET; AGED; AGED, 80 AND OVER; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEINS E; CROSS-SECTIONAL STUDIES; FEMALE; FINLAND; HUMAN; MALE; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0029037609     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.45.5.903     Document Type: Article

References (34)

1. Strittmatter WJ, Saunders AM, Schmechel D, et al. Apolipoprotein E: high affinity binding to 3-amyloid and increased frequency of type 4 allele in familial Alzheimer’s. Proc Natl Acad Sci USA 1993;90:1977-1981.
2. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science 1993;261:921-923.
3. Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele e4 with late-onset familial and sporadic Alzheimer’s disease. Neurology 1993;43:1467-1472.
4. Yu C-E, Payami H, Olson JM, Boehnke M, et al. The apolipoprotein E/CI/C1I gene cluster and late-onset Alzheimer’s disease. Amer J Hum Genet 1994;54:631-642.
5. Poirier J, Davignon J, Bouthillier D, Kogan S, Bertrand P, Gauthier S. Apolipoprotein E polymorphism and Alzheimer’s disease. Lancet 1993;342:697-699.
6. Noguchi S, Murakami K, Yamada N. Apolipoprotein E genotype and Alzheimer’s disease [letter]. Lancet 1993;342:737.
7. Saunders AM, Schmader K, Breitner JCS, et al. Apolipoprotein E e4 allele distributions in late-onset Alzheimer’s disease and in other amyloid-forming diseases. Lancet 1993;342:710-711.
8. Lucotte G, David F, Visvikis S, et al. Apolipoprotein E-e4 allele and Alzheimer’s disease [letter]. Lancet 1993;342:1309.
9. Mayeux R, Stem Y, Ottman R, et al. The apolipoprotein e4 allele in patients with Alzheimer’s disease. Ann Neurol 1993;34:752-754.
10. Anwar N, Lovestone S, Cheetham ME, Levy R, Powell JF. Apolipoprotein E-e4 allele and Alzheimer’s disease [letter]. Lancet 1993;342:1308-1309.
11. Rebeck GW, Peris TT, West HL, Sodhi P, Lipsitz LA, Hyman BT. Reduced apolipoprotein e4 allele frequency in the oldest old Alzheimer’s patients and cognitively normal individuals. Neurolopr 1994;44:1513-1516.
12. van Duijn CM, de Knijff P, Cruts M, et al. Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer’s disease. Nature Genet 1994;7:74-78.
13. Peacock ML, Fink JK. ApoE e4 allelic association with Alzheimer’s disease: independent confirmation using denaturing gradient gel electrophoresis. Neurology 1994;44:339- 341.
14. Schmechel DE, Saunders AM, Strittmatter WJ, et al. Increased amyloid [3-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci USA 1993;90:9649- 9653.
15. Pfeiffer E. A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. J Am Geriatr Soc 1975;23:433-441.
16. Katz S, Downs TD, Cash HR, Grotz RC. Progress in development of the index of ADL. Gerontologist 1970;1:20-30.
17. Lawton MP, Brody EM. Assessment of older people: self- maintaining and instructional activities of daily living. Gerontologist 1969;9:179-186.
18. Erkinjuntti T, Sulkava R, Wikstrom J, Autio L. Short portable mental status questionnaire as a screening test for dementia and delirium among the elderly. J Am Geriatr Soc 1987;35:412-416.
19. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 1984;34:939-944.
20. Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993;43:250-260.
21. Lukka M, Metso J, Ehnholm C. Apolipoprotein A-IV polymorphism in the Finnish population: gene frequencies and description of a rare allele. Hum Hered 1988;38:359-362.
22. Havekes L, de Knijeff P, Beisiegel U, Havinga J, Smit M, Klasen E. A rapid micromethod for apolipoprotein E pheno- typing directly in serum. J Lipid Res 1987;28:455-463.
23. Weisgraber KH, Innerarity TL, Mahley RW. Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site. J Biol Chem 1982;257:2519-2521.
24. Breslow NE, Day NE. Statistical methods in cancer research. Vol I—the analysis of case-control studies. IARC Scientific Publications No. 32. Lyon, France: International Agency for Research on Cancer, 1980.
25. Ehnhom C, Lukka M, Kuusi T, Nikkila E, Utermann G. Apolipoprotein E polymorphism in the Finnish population: gene frequencies and relation to lipoprotein concentrations. J Lipid Res 1986;27:227-235.
26. Lehtimaki T, Moilanen T, Viikari J, et al. Apolipoprotein E phenotypes in Finnish youths: a cross-sectional and 6-year follow-up study. J Lipid Res 1990;31:487-495.
27. Louhija J, Miettinen HE, Kontula K, Tikkanen MJ, Mietti- nen TA, Tilvis RS. Aging and genetic variation of plasma apolipoproteins: relative loss of the apolipoprotein e4 phenotype in centenarians. Arteriosclerosis Thrombosis 1993;14:1084-1089.
28. Borenstein M, Cohen J. Statistical power analysis: a computer program. Hillsdale, NJ: Lawrence Erlbaum, 1988.
29. Schachter F, Faure-Delanef L, Guenot F, et al. Genetic associations with human longevity at the APOE and ACE loci. Nature Genet 1994;6:29-32.
30. Sulkava R, Wikstrom J, Aromaa A, et al. Prevalence of severe dementia in Finland. Neurology 1985;35:1025-1029.
31. Henderson VW, Sobel E, Buckwalter JG. Survival in Alzheimer’s disease: longer for women than for men. Ann Neurol 1994;36:310.
32. Corder EH, Saunders AM, Risch NJ, et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nature Genet 1994;7:180-184.
33. Shoffner JM, Brown MD, Torroni A, et al. Mitochondrial DNA variants observed in Alzheimer disease and Parkinson disease patients. Genomics 1993;17:171-184.
34. Rebeck GW, Hyman BT. Apolipoprotein E—correction [letter]. Neurology 1995;45:598.